24.23  0.03 (0.12%)		12-31 19:00
Open: 24.21 High: 24.23 Volume: 198,448		Pre. Close: 24.2 Low: 24.21 Market Cap: 0(M)

Short term
Mid term
Targets	6-month :	28.3	1-year :	33.05
Resists	First :	24.22	Second :	28.3
Pivot price	24.22
Supports	First :	24.21	Second :	24.2
MAs	MA(5) :	24.22	MA(20) :	24.22
	MA(100) :	24.22	MA(250) :	22
MACD	MACD :	0	Signal :	0
%K %D	K(14,3) :	100	D(3) :	100
RSI	RSI(14): 71.5
52-week	High :	24.38	Low :	12.47

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ IIN ] has closed Bollinger Bands are 100% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 171 bars. This is a sign that the market may be about to initiate a new trend.

If tomorrow:	Open lower	Open higher
High:	24.29 - 24.41	24.41 - 24.5
Low:	23.87 - 24.04	24.04 - 24.17
Close:	24 - 24.25	24.25 - 24.45

IntriCon Corporation, together with its subsidiaries, designs, develops, engineers, manufactures, and distributes body-worn devices in the United States, Europe, Asia, and internationally. It offers micro-miniature products, microelectronics, micro-mechanical assemblies, high-precision injection-molded plastic components, and assemblies and software solutions for medical devices, hearing healthcare, and professional audio communication devices markets. The company also provides micro coils for surgical navigation clinical applications, such as interventional pulmonology and electrophysiology; joint engineering and manufacturing services for complex medical devices, including catheters covering a range of applications for cardiology, peripheral vascular, neurology, radiology, and pulmonology; bubble sensors and flow restrictors that monitor and control the flow of fluid in an intravenous infusion system; and safety needle products for original equipment manufacturing customers. In addition, it offers professional audio headset products used for emergency response needs in the fire, law enforcement, safety, aviation, and military markets; and a line of miniature ear- and head-worn devices used by performers and support staff in the music and stage performance markets. The company sells its hearing device products, and medical and professional audio communications products directly to hearing instrument manufacturers, distributors, and partnerships; and microphone products to the radio communication and professional audio industries, as well as markets and sells hearing aid devices directly to consumers through direct mail advertising, Internet, and call center. The company was formerly known as Selas Corporation of America and changed its name to IntriCon Corporation. The company was incorporated in 1930 and is headquartered in Arden Hills, Minnesota.

Thu, 18 Apr 2024
Do Institutions Own IntriCon Corporation (NASDAQ:IIN) Shares? - Yahoo Movies Canada

Wed, 11 Oct 2023
Intricon hires Shaun Blakeman as CFO - Medical Design & Outsourcing

Tue, 10 Oct 2023
Intricon Corp. building manufacturing facility in Costa Rica - The Business Journals

Thu, 17 Aug 2023
Intricon to open first facility for sensor-driven medical devices - Today's Medical Developments

Mon, 28 Feb 2022
Intricon Reports Fourth Quarter and Full Year 2021 Results - GlobeNewswire

Mon, 28 Feb 2022
Arden Hills' Intricon selling for $241 million to private-equity group - Star Tribune

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Outperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Outperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Neutral
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Neutral
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Outperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Medical - Instruments & Supplies
Shares Out	9 (M)
Shares Float	8 (M)
Held by Insiders	8.4 (%)
Held by Institutions	66.1 (%)
Shares Short	130 (K)
Shares Short P.Month	194 (K)

EPS	0.1
EPS Est Next Qtrly	0.07
EPS Est This Year	0.34
EPS Est Next Year	0.4
Book Value (p.s.)	10.18
Profit Margin	-0.1 %
Operating Margin	1.4 %
Return on Assets (ttm)	0.9 %
Return on Equity (ttm)	-0.1 %
Qtrly Rev. Growth	6.1 %
Gross Profit (p.s.)	3.43
Sales Per Share	13.69
EBITDA (p.s.)	0.81
Qtrly Earnings Growth	0 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	0 (M)

PE Ratio	220.27
PEG Ratio	0
Price to Book value	2.38
Price to Sales	1.76
Price to Cash Flow	505.62

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	2001-09-11